Cochlear Implantation for Profound Hearing Loss After Multimodal Treatment for Neuroblastoma in Children (Q30397139)

14 November 2017

Cochlear Implantation for Profound Hearing Loss After Multimodal Treatment for Neuroblastoma in Children (English)

1 reference

14 November 2017

1 reference

1 reference

1 reference

Nam-Gyu Ryu

1

1 reference

14 November 2017

Il Joon Moon

2

1 reference

14 November 2017

Young Soo Chang

3

1 reference

14 November 2017

Byoung Kil Kim

4

1 reference

14 November 2017

Won-Ho Chung

5

1 reference

14 November 2017

Yang-Sun Cho

6

1 reference

14 November 2017

Sung Hwa Hong

7

1 reference

14 November 2017

10 November 2015

1 reference

Clinical and Experimental Otorhinolaryngology

14 November 2017

1 reference

14 November 2017

8

1 reference

14 November 2017

4

1 reference

14 November 2017

329-334

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

14 November 2017

start time

1 January 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: high incidence of endocrine and growth problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Cisplatin ototoxicity affecting cochlear implant benefit

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Cisplatinum ototoxicity in children, long-term follow up

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Residual Hearing Preservation After Pediatric Cochlear Implantation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Practical grading system for evaluating cisplatin ototoxicity in children

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Auditory late effects of childhood cancer therapy: a report from the Children's Oncology Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Cochlear implantation following treatment for medulloblastoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

The epidemiology of neuroblastoma: a review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Pattern of hearing loss following cochlear implantation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Long-term follow-up of children with high-risk neuroblastoma: the ENSG5 trial experience

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Hearing preservation after cochlear implantation using deeply inserted flex atraumatic electrode arrays.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4661246

Neuroblastoma incidence and survival in European children (1978–1997): Report from the Automated Childhood Cancer Information System project

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26622949

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3342/CEO.2015.8.4.329

1 reference

release_iafrxq3cu5gxjhogkiqca5ulni

14 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iafrxq3cu5gxjhogkiqca5ulni

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

14 November 2017

PubMed publication ID

26622949

1 reference